Abstract
Liver cirrhosis favors portal hypertension which causes complications like variceal bleeding, therapy-refractory ascites, and hepatorenal syndrome. Transjugular intrahepatic portosystemic shunt (TIPS) is used for the treatment of portal hypertension. However, parenchymal portal venous flow after TIPS insertion is reduced. TIPS therefore might induce ischemic liver injury which has been discussed to favor hepatocarcinogenesis resulting in the development of hepatocellular cancer (HCC).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
